Robert Haddad, MD
Associate Professor, Department of Medicine, Harvard Medical School
Associate Professor of Medicine, Medical Oncology, Dana-Farber Cancer Institute
DF/HCC Program AffiliationHead and Neck Cancer
Dr. Haddad current research activity involves the use of concurrent and sequential chemoradiotherapy regimens for patients with locally advanced and metastatic head and neck cancer . He is leading numeous trials of novel agents in head and neck cancer , particularly in the areas of immunotherapy and novel biologic agents . Further, his research interests also include the role of the human papilloma virus (HPV) as a cause of head and neck cancer, particularly in the effect of such infection on treatment and prognosis and in the search for in HPV-related biomarkers that can be useful for early detection, risk stratification, and detection of early relapse. Dr. Haddad is a member of several professional societies, including the American Society of Clinical Oncology, American Association for Cancer Research, European Society of Medical Oncology , and the American Society for Therapeutic Radiology and Oncology. Dr. Haddad lectures extensively on head and neck cancer, both on the national, and international level.
View All Publications